---
title: "Vimta Labs Ltd (VIMTALABS) — Share Price, Financials & Analysis"
symbol: "VIMTALABS"
company: "Vimta Labs Ltd"
canonical: "https://tapetide.com/stocks/VIMTALABS"
isin: "INE579C01029"
nse_symbol: "VIMTALABS"
bse_code: "524394"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 2791.61
generated_at: "2026-09-13T18:37:27.537Z"
---

# Vimta Labs Ltd (VIMTALABS)

Canonical page: https://tapetide.com/stocks/VIMTALABS

## Company

- **NSE Symbol:** VIMTALABS
- **BSE Code:** 524394
- **ISIN:** INE579C01029
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2005-12-15
- **CEO:** Dr. Sivalinga Prasad Vasireddi
- **Employees:** 1315
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** vimta.com

## About

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]

## Latest Price

- **Price:** ₹629.6
- **Change:** -5.35 (-0.84%)
- **Open:** ₹635.8
- **Day High:** ₹635.8
- **Day Low:** ₹623.25
- **Previous Close:** ₹634.95
- **Volume:** 75010
- **As Of:** 2026-09-11T10:25:56+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:37.624962Z.

- **Market Cap:** ₹2791.61 Cr
- **Classification:** Microcap
- **P/E (reported):** 35.6
- **P/E (TTM):** 35.27
- **EPS (TTM):** ₹17.85
- **EPS (reported):** ₹18.53
- **Book Value:** ₹102.24
- **Price to Book:** 6.21
- **Dividend Yield:** 0.31%
- **ROE:** 12.83%
- **ROCE:** 16.36%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹322.3 Cr
- **Net Income:** ₹41 Cr
- **EBITDA:** ₹90.8 Cr
- **52-Week High:** ₹851
- **52-Week Low:** ₹376.05
- **RSI (14):** 52.89

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 90.39 | 9% |
| growth | 50 | 9% |
| momentum | 70.67 | 12% |
| ownership | 39.25 | 24% |
| quality | 68.14 | 22% |
| valuation | 47.32 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 30.0% CAGR over last 5 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -30.76% | 3.08% | 150.06% |
| ebitda margin growth | 32.99% | -7.88% | -3.59% | 57.02% |
| net income growth | 40.52% | -14.94% | 19% | 30% |
| revenue growth | 11.36% | 0.22% | 9% | 14% |
| roce | 38.72% | -26.21% | -25.77% | 16.18% |
| roe | 40.98% | -24.97% | 15.86% | 223.99% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 64 | 73 | 73 | 75 | 85 | 90 | 94 | 98 | 102 | 99 | 109 | 109 |
| Expenses | 48 | 50 | 47 | 49 | 55 | 57 | 61 | 64 | 68 | 64 | 70 | 72 |
| Operating Profit | 17 | 23 | 26 | 26 | 30 | 33 | 33 | 34 | 34 | 34 | 39 | 37 |
| OPM % | 26 | 31 | 36 | 35 | 35 | 37 | 35 | 35 | 34 | 35 | 36 | 34 |
| Other Income | 0 | -1 | -1 | -1 | -1 | 5 | 2 | 2 | 3 | 0 | 3 | 4 |
| Interest | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 9 | 8 | 8 | 8 | 8 | 10 | 9 | 10 | 10 | 11 | 13 | 13 |
| Profit before tax | 8 | 13 | 16 | 17 | 20 | 28 | 25 | 25 | 26 | 23 | 29 | 28 |
| Tax % | 25 | 25 | 24 | 26 | 24 | 23 | 27 | 25 | 24 | 25 | 27 | 26 |
| Net Profit | 6 | 9 | 12 | 12 | 15 | 22 | 18 | 19 | 20 | 18 | 21 | 21 |
| EPS in Rs | 1.34 | 2.14 | 2.79 | 2.77 | 3.44 | 4.84 | 4.12 | 4.24 | 4.47 | 3.94 | 4.73 | 4.71 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 183 | 213 | 181 | 209 | 276 | 315 | 289 | 344 | 407 | 419 |
| Expenses | 138 | 155 | 151 | 156 | 196 | 222 | 195 | 222 | 266 | 274 |
| Operating Profit | 45 | 58 | 30 | 53 | 80 | 94 | 94 | 122 | 142 | 145 |
| OPM % | 25 | 27 | 17 | 25 | 29 | 30 | 33 | 35 | 35 | 35 |
| Other Income | 1 | 2 | 3 | 1 | 0 | 3 | -4 | 5 | 7 | 9 |
| Interest | 5 | 5 | 4 | 2 | 2 | 3 | 2 | 2 | 1 | 1 |
| Depreciation | 16 | 20 | 21 | 23 | 23 | 31 | 33 | 35 | 44 | 46 |
| Profit before tax | 26 | 35 | 8 | 28 | 55 | 64 | 55 | 90 | 104 | 107 |
| Tax % | 36 | 28 | 17 | 25 | 26 | 26 | 25 | 25 | 25 | — |
| Net Profit | 16 | 25 | 7 | 21 | 41 | 47 | 41 | 67 | 78 | 80 |
| EPS in Rs | 3.72 | 5.73 | 1.57 | 4.81 | 9.29 | 10.68 | 9.26 | 15.13 | 17.35 | 17.85 |
| Dividend Payout % | 27 | 17 | 0 | 21 | 11 | 9 | 11 | 7 | 12 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 9 |
| Reserves | 132 | 148 | 167 | 169 | 190 | 229 | 276 | 310 | 374 | 448 |
| Borrowings | 44 | 40 | 26 | 32 | 30 | 19 | 15 | 19 | 9 | 3 |
| Other Liabilities | 42 | 40 | 40 | 39 | 49 | 54 | 65 | 61 | 79 | 102 |
| Total Liabilities | 222 | 232 | 237 | 245 | 273 | 306 | 360 | 394 | 467 | 562 |
| Fixed Assets | 88 | 140 | 135 | 131 | 128 | 162 | 168 | 166 | 230 | 305 |
| CWIP | 53 | 0 | 4 | 2 | 17 | 0 | 12 | 59 | 38 | 18 |
| Investments | 0 | 0 | 0 | 6 | 6 | 6 | 6 | 0 | 0 | 2 |
| Other Assets | 80 | 92 | 99 | 105 | 122 | 138 | 174 | 170 | 198 | 237 |
| Total Assets | 222 | 232 | 237 | 245 | 273 | 306 | 360 | 394 | 467 | 562 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 24 | 33 | 39 | 24 | 37 | 59 | 87 | 61 | 94 | 147 |
| Cash from Investing Activity | -39 | -24 | -16 | -20 | -32 | -38 | -57 | -76 | -76 | -130 |
| Cash from Financing Activity | 13 | -8 | -23 | -1 | -5 | -16 | -11 | -2 | -16 | -10 |
| Net Cash Flow | -2 | 1 | 1 | 3 | 1 | 5 | 19 | -17 | 2 | 7 |
| Free Cash Flow | -16 | 9 | 23 | 10 | 5 | 20 | 37 | -14 | 17 | 47 |
| CFO/OP | 107 | 86 | 85 | 101 | 84 | 94 | 106 | 81 | 95 | 121 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 101 | 111 | 100 | 117 | 128 | 102 | 93 | 110 | 113 | 95 |
| Inventory Days | 183 | 209 | 199 | 191 | 140 | 154 | 195 | 260 | 210 | 203 |
| Days Payable | 184 | 148 | 115 | 114 | 139 | 108 | 124 | 87 | 88 | 79 |
| Cash Conversion Cycle | 100 | 172 | 184 | 194 | 128 | 147 | 164 | 283 | 235 | 219 |
| Working Capital Days | 22 | 62 | 78 | 64 | 89 | 87 | 78 | 98 | 96 | 83 |
| ROCE % | 11 | 17 | 21 | 6 | 14 | 24 | 24 | 20 | 25 | 25 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 37.01% | 36.98% | 36.92% | 36.89% | 36.89% | 36.76% | 36.7% | 36.67% | 35.99% | 35.9% | 35.85% | 35.67% |
| FIIs | 2.74% | 2.88% | 5.13% | 5.16% | 3.31% | 3.81% | 3.66% | 3.49% | 4.33% | 4.59% | 4.89% | 4.42% |
| DIIs | 1.5% | 1.49% | 1.5% | 1.49% | 0% | 1.16% | 1.43% | 1.42% | 0.87% | 0.11% | 0.14% | 0.37% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 25% | 25.15% | 23.08% | 23.13% | 26.53% | 25.09% | 25.17% | 24.02% | 24.62% | 25.12% | 25.01% | 25.03% |
| Others | 33.75% | 33.5% | 33.37% | 33.33% | 33.27% | 33.18% | 33.03% | 34.4% | 34.18% | 34.29% | 34.11% | 34.52% |
| No. of Shareholders | 18429 | 19957 | 18550 | 19054 | 20114 | 21156 | 26183 | 29867 | 55933 | 54467 | 51623 | 50190 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 6 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 640.76 | Sell |
| EMA (10) | 634.25 | Sell |
| SMA (20) | 632.33 | Sell |
| EMA (20) | 631.6 | Sell |
| SMA (50) | 609.25 | Buy |
| EMA (50) | 609.24 | Buy |
| SMA (100) | 558.02 | Buy |
| EMA (100) | 578.08 | Buy |
| SMA (200) | 533.3 | Buy |
| EMA (200) | 555.25 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.83 | Neutral |
| MACD (12,26,9) | 5.99 | Sell |
| Stochastic (14,3,3) | 32.68 | Neutral |
| ADX (14) | 25 | Neutral |
| Williams %R (14) | -69.45 | Neutral |
| ATR (14) | 22.48 | High Volatility |
| ROC (12) | 0.3 | Buy |
| Stoch RSI (14) | 8.02 | Buy |
| UO (7,14,28) | 38.33 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:44:37.871407+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6020695b-4438-4d1d-acc4-9c9bf3230907.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e15998-f23a-4725-9dfd-eae32c7f8d38.pdf) |
| 2026-09-01 | [Clarification Regarding Increase In Volume Of Our Securities Across Exchanges.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de1a87a6-dc35-4d66-8e8f-ba38f5a427c8.pdf) |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=322cfcc1-0c91-4673-9cd2-6e902f96b92a.pdf) |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=417d7838-2b92-4159-a608-76c12adb9dfa.pdf) |
| 2026-08-21 | [Intimation On Cyber Security Incident](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42976229-5d51-45f1-a10a-4093da10af49.pdf) |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07b90504-d8cd-4022-9e5e-e467d409b143.pdf) |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=006269a9-51e2-4fcf-bbc1-20f5a1055b59.pdf) |
| 2026-07-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e34691b6-21b6-4ff0-8082-f22fefb43e3f.pdf) |
| 2026-07-20 | [Board Meeting Outcome for Q1 FY- 2026-27 - Unaudited Financial Results.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a0f1989-ddc0-4d5b-ae42-9319cb41aefe.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Allotment of ESOPs under Vimta Labs Employee Stock Option Plan 2021. | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 9 Mar - Allotment of ESOPs under Vimta Labs Employee Stock Option Plan 2021.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4e69af01-c01c-450f-8969-be3e60e40bc7.pdf) |
| 8 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8343e2f5-2f0c-41fb-b50a-033a18870db1.pdf) |
| 7 May - Newspaper Publication of Audited Financial Results - Q4 FY 2025-26. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 May - Newspaper Publication of Audited Financial Results - Q4 FY 2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fc37994b-d351-4ade-921c-7548ef1ca0ec.pdf) |
| 6 May - Vimta Labs reported FY26 revenue of Rs. 4,163 Mn, PAT of Rs. 775 Mn, and Q4 results. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 May - Vimta Labs reported FY26 revenue of Rs. 4,163 Mn, PAT of Rs. 775 Mn, and Q4 results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3ea5ff99-5e6a-418c-9aff-0a5eb292e95a.pdf) |
| 6 May - Q4 FY2025-26 earnings call audio recording uploaded on company website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 6 May - Q4 FY2025-26 earnings call audio recording uploaded on company website.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4af6d882-b868-4b66-a607-48d8a06a68e8.pdf) |
| 6 May - Dr. S. P. Vasireddi reappointed Executive Chairman for five years from 1 July 2026, subject to AGM approval. | [Announcement under Regulation 30 (LODR)-Change in Management 6 May - Dr. S. P. Vasireddi reappointed Executive Chairman for five years from 1 July 2026, subject to AGM approval.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0bd86a22-1852-44a2-a641-0a4b44987636.pdf) |
| 6 May - Board recommended ₹2 per share dividend for FY2025-26; record date 18 June 2026. | [Corporate Action-Board approves Dividend 6 May - Board recommended ₹2 per share dividend for FY2025-26; record date 18 June 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8d0ed6b7-1489-458e-af80-771f5e4b57f6.pdf) |
| 31 Mar - Trading window closed from 1 April 2026 until 48 hours after audited Q4/FY2025-26 results. | [Closure of Trading Window 31 Mar - Trading window closed from 1 April 2026 until 48 hours after audited Q4/FY2025-26 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a634d3e-80b5-460a-9cf3-2472e33efc84.pdf) |
| 29 Apr - Of Schedule of Analyst/Investor Conference Call post announcement of Q4 Financial Results - FY 2025-26 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 Apr - Of Schedule of Analyst/Investor Conference Call post announcement of Q4 Financial Results - FY 2025-26](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2daee446-7419-49e7-bc1f-66ad46730831.pdf) |
| 29 Apr - Board to meet on 6 May 2026 for FY26 audited results and possible dividend recommendation. | [Board Meeting Intimation for Intimation Of Board Meeting Q4- Audited Financial Results- FY 2025-26 29 Apr - Board to meet on 6 May 2026 for FY26 audited results and possible dividend recommendation.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9becd86a-7419-459f-b76f-004c222fa684.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f98f255-8a33-47e6-b7cf-726e5f5f7b71.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e37bbe73-8c54-4f85-8d97-2757bbb62b1f.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0410b286-a37c-4f9f-828b-a0c3c74c4986.pdf) |
| 2025-11-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de747917-7ee9-4484-a7e4-7e80223b9997.pdf) |
| 2025-07-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d38dc60-68a4-4c78-aef8-cf23dd9d117d.pdf) |
| 2025-05-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31a64bec-b928-4342-9fc0-31c3088c9066.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bff3d4f-6b37-4ff3-a84e-145e8421a703.pdf) |
| 2024-07-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1602195-ebdc-4d36-9261-27a1a21cfe71.pdf) |
| 2024-05-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a4769d-9b87-46cd-8012-8f7bf5a1aaea.pdf) |
| 2024-02-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c8a444e-6465-40ad-8d49-1cdbf8f85925.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-20 | [Q1 FY- 2026-27 - Unaudited Financial Results.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c08aad1-3fb3-4060-914a-c4c0247750d9.pdf) |
| 2026-05-06 | [Q4 FY- 2025-26 - Audited Financial Results.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebfc0a3a-ac0b-4cde-ae01-5108c2d8eb24.pdf) |
| 2026-01-28 | [Q3 FY- 2025-26 - Unaudited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f47134c-1833-4c0c-921c-6696affec553.pdf) |
| 2025-11-03 | [Q2 FY- 2025-26 - Unaudited Financial Results.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c711df84-a7b1-48a9-8c6a-b91e9563dd2f.pdf) |
| 2025-07-17 | [Results- Financial Results Q1- 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c1ddcb6-e7fd-43d2-98e4-8847cb2d7d28.pdf) |
| 2025-04-28 | [The Board Of Director In Their Meeting Held Today Approved Financial Result Dividend And Bonus Along With Other Agenda.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=128e723c-5230-4f85-9508-6befd5c1886c.pdf) |
| 2025-01-24 | [Results-Financial Results For The Quarter Ended 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d23c8caf-57c3-4f7c-84d3-09ee9c9725d6.pdf) |
| 2024-11-08 | [Results - Financials Results For 30Th September 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2aeba0f-3008-4113-bee0-62f177ad68a2.pdf) |
| 2024-07-17 | [Quarterly Financial Results - 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5de87859-24e4-432d-a50c-aa9bbb7a8385.pdf) |
| 2024-05-18 | [Results - Financial Results 31.03.2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6db41f54-a10c-4d39-882e-1fb06ebb0f74.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c618f71-8b20-4479-b9da-7d6e353f1360.pdf) |
| 2026-05-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9341c6df-2a10-4aad-891b-44209ad059c8.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6d80f3e-9a8e-4e31-86e9-8ff50b19cad3.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=282156ae-d831-4232-a288-bfca08e9e180.pdf) |
| 2025-07-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a58210b2-ea70-455f-bb6f-58046d9da442.pdf) |
| 2025-07-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=035a7fe4-b60d-4dd0-840f-5838fcbd2985.pdf) |
| 2025-07-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f8089a4-5c8c-4a46-af28-60e6b02dcbea.pdf) |
| 2025-04-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0efff9f8-aa04-4dc6-b59e-e5b6e79ab890.pdf) |
| 2025-04-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14eecef4-8d89-4a29-9687-76eaa2951fe2.pdf) |
| 2025-01-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d0a9b1-7a1c-46c4-a02c-b2c912227061.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f6d4f76-21c5-4371-baad-d4c576e2376c.pdf) |
| 2026-05-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4af6d882-b868-4b66-a607-48d8a06a68e8.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e70518-20b1-4f7d-8031-5aa464721ee5.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2acfd21a-e75f-4953-8f37-c4cfc20089d2.pdf) |
| 2025-07-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58a51f83-3265-444e-bfec-9a7fe1873b33.pdf) |
| 2025-04-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2b76305-b80b-4b4b-99f9-53dbce4b1a46.pdf) |
| 2024-11-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d10d9a24-cf84-4f74-8b3e-e72f4e0e4027.pdf) |
| 2024-07-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca3cbdbe-9764-4c99-a2cb-753106032111.pdf) |
| 2024-05-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dd01404-2fc7-4860-9099-2685a3748577.pdf) |
| 2024-02-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fc7a055-3c6b-490a-a537-388fa51d7d27.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c56e18a-8874-428b-acf4-a43b35eb6101.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de747917-7ee9-4484-a7e4-7e80223b9997.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4bff3d4f-6b37-4ff3-a84e-145e8421a703.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9426c8fe-d7f4-4ecb-99dd-cab16195d13e.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/acc031c4-9df5-441b-981c-6ccd624d86e4.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e37bbe73-8c54-4f85-8d97-2757bbb62b1f.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e37bbe73-8c54-4f85-8d97-2757bbb62b1f.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/31a64bec-b928-4342-9fc0-31c3088c9066.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/41a4769d-9b87-46cd-8012-8f7bf5a1aaea.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5b013f1e-713e-4095-8f55-e1d3c747ad27.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7393a5a0-f439-4989-bd79-ebde9b9d9ab8.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1ef36a07-4cf7-4609-ad1d-9eea4bb54060.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/55776a1e-570b-4bb7-90e2-a352f7af2bc3.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e48ff04-4054-414f-a24e-483cbeb2e9d8.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524394/73037524394.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:27.537Z.